Replies to post #620040 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

LOL . This a good one ... for a laugh. The things you come up with, fudster Ex, reveal a superior talent for fud.

[Margin Buu]

A total of 331 patients were enrolled in the trial, with 232 randomized to the DCVax-L group and 99 to the placebo group. Median OS (mOS) for the 232 patients with nGBM receiving DCVax-L was 19.3 (95% CI, 17.5-21.3) months from randomization (22.4 months from surgery) vs 16.5 (95% CI, 16.0-17.5) months from randomization in control patients (HR?=?0.80; 98% CI, 0.00-0.94; P?=?.002). Survival at 48 months from randomization was 15.7% vs 9.9%, and at 60 months, it was 13.0% vs 5.7%. For 64 patients with rGBM receiving DCVax-L, mOS was 13.2 (95% CI, 9.7-16.8) months from relapse vs 7.8 (95% CI, 7.2-8.2) months among control patients (HR, 0.58; 98% CI, 0.00-0.76; P?<?.001). Survival at 24 and 30 months after recurrence was 20.7% vs 9.6% and 11.1% vs 5.1%, respectively. Survival was improved in patients with nGBM with methylated MGMT receiving DCVax-L compared with external control patients (HR, 0.74; 98% CI, 0.55-1.00; P?=?.03). https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

by, exwannabe.

[supersteve13]

20-25% long term survivors according to Liau. Wonder whom to believe, her or this waste of oxygen who is a known liar. :)